Iron Protein Succinylate (Iron Protein Succinylate)
Overview of Iron Protein Succinylate
Iron protein succinylate may be the most effective oral supplement for correcting iron deficiency anemia (IDA). IPS is a proprietary form of ferric iron (Fe+++) bound with a chemically modified protein (casein) in a process called succinylation, which dramatically stabilizes the complex. This process is responsible for the specific way in which IPS is totally dependent on pH for absorption. Because IPS is insoluble in the stomach, it completely bypasses the stomach without exposing the gastric mucosa to iron. This is the optimal method to transport iron where absorption takes place � the duodenum. Here, IPS becomes completely soluble in the duodenum, where the pH level allows for rapid hydrolysis of the protein component, and liberation of the elemental ferric iron for immediate absorption. IPS is the only iron compound that provides this proven, highest degree of tolerability. Since IPS provides a steady, controlled release of iron in a low concentration form, the iron overload is nearly impossible.
Indication of Iron Protein Succinylate
Iron Protein Succinylate is primarily indicated in conditions like Iron deficiency anaemia.
Contraindication of Iron Protein Succinylate
Iron Protein Succinylate is contraindicated in conditions like Hemochromatosis,Hepatitis,Hypersensitivity to any component of product.
Side Effects of Iron Protein Succinylate
The symptomatic adverse reactions produced by Iron Protein Succinylate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Vomiting, Diarrhea, Constipation, Epigastric discomfort, Light headedness, Black stool.
Precautions of Iron Protein Succinylate
High doses of iron supplements should be avoided in children. Particularly in the young iron supplements should be avoided during acute infections as iron is an important nutrient for bacteria. Iron supplements should not be given in cases of peptic ulcers and inflammatory bowel disease because iron can have a corrosive effect and exacerbate these conditions. Blood transfusion recipients and sufferers of thalassemia, hemochromatosis and hepatitis should also avoid iron supplements. Iron preparations by injection may cause a flare-up of rheumatoid arthritis.